Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis
BJU International, 06/24/09
Planas J et al. - Treatment with once-weekly 70 mg alendronate significantly improved the BMD at the lumbar spine and femoral neck in patients with prostate cancer with severe osteopenia or osteoporosis and on ADT, and significantly decreased the risk of femoral neck fracture.
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Cardiovascular diseases and risk of hip fracture
JAMA, 10/23/09
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150mg and risedronate 150mg
Current Medical Research and Opinion, 10/22/09
Today in Trauma...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of intra-articular lidocaine as analgesia in anterior shoulder dislocation: a review and meta-analysis of the literature
Canadian Journal of Rural Medicine, 10/22/09
Peak bone mineral density, lean body mass and fractures
Bone , 11/03/09
The Potential Role of Prophylactic/Functional Knee Bracing in Preventing Knee Ligament Injury
Sports Medicine, 10/26/09
Article Search
Sponsor


See Latest Articles


